Stock 688273 NANJING MEDLANDER MEDICAL TECHNOLOGY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Nanjing Medlander Medical Technology Co.,Ltd.

Equities

688273

CNE100005PV8

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-06-03 pm EDT 		5-day change 1st Jan Change
21.74 CNY -2.42% Intraday chart for Nanjing Medlander Medical Technology Co.,Ltd. -0.87% -34.73%
May. 31 Medlander Medical Technology Scraps 193 Million Yuan Maidou Health Deal MT
May. 30 Nanjing Medlander Medical Technology Co.,Ltd. cancelled the acquisition of 55% stake in Nanjing Maidou Health Technology Co., Ltd. from Wu Henglong, Zheng Weifeng, Nanjing Xinlan Equity Investment Partnership (Limited Partnership) and Nanjing Maichuang Enterprise Management Partnership Enterprise (Limited Partnership) CI

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 3,260 3,352 2,150 -
Enterprise Value (EV) 1 3,260 3,352 2,150 2,150
P/E ratio 22 x 37.1 x 13 x 9.45 x
Yield - 1.8% 2.76% 2.99%
Capitalization / Revenue - 9.83 x 3.78 x 2.98 x
EV / Revenue - 9.83 x 3.78 x 2.98 x
EV / EBITDA - 28.4 x 10.8 x 7.82 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book - 2.49 x 1.48 x 1.33 x
Nbr of stocks (in thousands) 100,000 100,620 98,890 -
Reference price 2 32.60 33.31 21.74 21.74
Announcement Date 2/26/23 2/23/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 - 340.8 568 722
EBITDA 1 - 118 199 275
EBIT 1 - 102.5 199 270
Operating Margin - 30.07% 35.04% 37.4%
Earnings before Tax (EBT) 1 - 101.5 199 270
Net income 1 123 89.82 168 231
Net margin - 26.35% 29.58% 31.99%
EPS 2 1.480 0.8982 1.670 2.300
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share 2 - 0.6000 0.6000 0.6500
Announcement Date 2/26/23 2/23/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - 6.63% 11.4% 14%
ROA (Net income/ Total Assets) - 5.8% 10% 12.2%
Assets 1 - 1,549 1,680 1,893
Book Value Per Share 2 - 13.40 14.70 16.40
Cash Flow per Share 2 - 1.360 1.660 2.950
Capex 1 - 74.6 11 11
Capex / Sales - 21.88% 1.94% 1.52%
Announcement Date 2/26/23 2/23/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Nanjing Medlander Medical Technology Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
21.74
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
NANJING MEDLANDER MEDICAL TECHNOLOGY CO.,LTD. Stock Nanjing Medlander Medical Technology Co.,Ltd.
-34.73% 297M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.32% 217B
DANAHER CORPORATION Stock Danaher Corporation
+13.83% 195B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+20.48% 144B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+31.33% 112B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+2.85% 65.83B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+14.64% 52.67B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+2.72% 49.86B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-5.88% 38.18B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+0.25% 35.39B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. 688273 Stock
  4. Financials Nanjing Medlander Medical Technology Co.,Ltd.